FED is expected to start to cut rates in September and smart money will start to find alternative investment vehicles to put their money in. These stocks are showing good potential. I already have positions in all of them but still may add more to my positions. Disclaimer: Not financial advice. Do your own analysis and research.
Hey folks, happy Thursday! I am currently on the weekly chart for CODX and it seems to be forming a long-term bull flag with an ABCDE correction pattern. The long position might take a few weeks to play out but it looks bullish long term wise.
Confluence within the fib levels and the trend lines. Descedning triangle gonna break down savagely like the rest of the market imminently. Will be bringing in my tomato plants.
Chembio Diagnostics' analysts are forecasting revenues of US$54m in 2021, a substantial 56% improvement in sales compared to the last year. CEMI follows its bigger more profitable brother CODX in price action. Depending on the future development of the global pandemic, those stocks could grow rapidly. On 12/3/2020 Craig Hallum brokerage Upgraded the stock from...
Abnormal volume & undervalued 1 Year Price Target: $23.00 for a 180+/-% return About: Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as...
If you missed the 2x from my previews call: Then you should know that the stock was hit by a big selloff, even though they beat the consensus analyst revenue estimate in Q4 with sales being higher 24% year over year to $27.1 million. This might be your 50% upside potential chance. If you are interested to test some amazing BUY and SELL INDICATORS which give...
in buy zone around 10.10, target 11.67. stop loss 9.40 r/r 2.29
Haven't shared a chart for this since June, but it's finally time. - Biden presidency = continued demand for masks for the foreseeable future - Premiums are still surprisingly cheap - Only $250MM market cap, so a move to $100 isn't crazy at all (would barely put it over $1B) - Clear trend break - Makes vertical moves out of accumulation
...$FLDM ..w earnings early Feb and as Covid19 plays run today, diagnostics/ genomes all in ONE here w/ FLDM
Co-Diagnostics Wins Regulatory Approval to Sell COVID-19 Tests in Europe! Nov 17MT Newswires: Co-Diagnostics (CODX) said it has received regulatory authorization to sell its Logix Smart ABC and SARS-CoV-2 multiplex tests for the diagnosis of COVID-19 in markets that accept CE markings. The indicators are looking bullish on lower timeframes, which can mean a...
I have out lined the following TP: 50.00 SL: Below local HTF support. Pfizer sitting on fib support follow news of corona virus vaccine. It is reasonable to assume a break of ATH's in the future. Pays a good dividend in addition to the projected upside.
This could be a continuation of a downtrend or we can see a bounce tomorrow. NASDAQ:CODX
This is follow-up to previous forecast on CODX. Gap fill is possible. Not sure what will happen after that.
Per tutti quelli che seguono lo stock e mi seguono su etoro e hanno visto l ultimo video dove mi sono posizionato su CODX. Sto osservando questa falling wedge oraria per un climax. E una rottura del pattern a breve.
$CODX is a company focused on commercializing molecular diagnostics for infectious diseases, including COVOID-19 with their testing kit. With COVOID-19 infections slowly ticking up in the US and more cities are are temporarily shutting down, we might see more demand in these testing kits. $CODX has been flagging in its channel since June 12th and a breakout can...